Investor List:

Top Material Science Series B Investors in Los Angeles / Southern California (7)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Material Science investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Carolyn Zhao, Managing Partner at Fourward Ventures
Carolyn Zhao
Fourward Ventures·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Los Angeles (CA)
Investors in Material Science (Seed), Investors in Wellness & Fitness (Seed), Investors in Food and Beverage (Seed), Investors in SMB Software (Seed), Investors in Entertainment & Sports (Seed), Investors in Material Science (Seed), Investors in E-commerce (Seed), Investors in Wellness & Fitness (Seed), Investors in Enterprise (Seed), Investors in Entertainment & Sports (Seed), Investors in Food and Beverage (Seed), Investors in SMB Software (Seed), Investors in E-commerce (Seed), Investors in Enterprise (Seed), Investors in Material Science (Series A), Investors in Wellness & Fitness (Series A), Investors in Food and Beverage (Series A), Investors in SMB Software (Series A), Investors in Entertainment & Sports (Series A), Investors in Material Science (Series A), Investors in E-commerce (Series A), Investors in Enterprise (Series A), Investors in Wellness & Fitness (Series A), Investors in Entertainment & Sports (Series A), Investors in Food and Beverage (Series A), Investors in SMB Software (Series A), Investors in E-commerce (Series A), Investors in Enterprise (Series A), Investors in Material Science (Series B), Investors in Wellness & Fitness (Series B), Investors in Food and Beverage (Series B), Investors in Entertainment & Sports (Series B), Investors in SMB Software (Series B), Investors in E-commerce (Series B), Investors in Material Science (Series B), Investors in Wellness & Fitness (Series B), Investors in Enterprise (Series B), Investors in Entertainment & Sports (Series B), Investors in Food and Beverage (Series B), Investors in SMB Software (Series B), Investors in E-commerce (Series B), Investors in Enterprise (Series B), Investors in Los Angeles / Southern California (Other Lists)
Photo of Will Ward, Managing Partner at Fourward Ventures
Will Ward
Fourward Ventures·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Los Angeles (CA)
Investors in Material Science (Seed), Investors in Wellness & Fitness (Seed), Investors in Food and Beverage (Seed), Investors in SMB Software (Seed), Investors in Entertainment & Sports (Seed), Investors in E-commerce (Seed), Investors in Material Science (Seed), Investors in Wellness & Fitness (Seed), Investors in Enterprise (Seed), Investors in Entertainment & Sports (Seed), Investors in Food and Beverage (Seed), Investors in SMB Software (Seed), Investors in E-commerce (Seed), Investors in Enterprise (Seed), Investors in Material Science (Series A), Investors in Wellness & Fitness (Series A), Investors in Food and Beverage (Series A), Investors in Entertainment & Sports (Series A), Investors in SMB Software (Series A), Investors in Material Science (Series A), Investors in E-commerce (Series A), Investors in Wellness & Fitness (Series A), Investors in Enterprise (Series A), Investors in Entertainment & Sports (Series A), Investors in Food and Beverage (Series A), Investors in SMB Software (Series A), Investors in E-commerce (Series A), Investors in Enterprise (Series A), Investors in Material Science (Series B), Investors in Wellness & Fitness (Series B), Investors in Food and Beverage (Series B), Investors in SMB Software (Series B), Investors in Entertainment & Sports (Series B), Investors in E-commerce (Series B), Investors in Material Science (Series B), Investors in Wellness & Fitness (Series B), Investors in Enterprise (Series B), Investors in Food and Beverage (Series B), Investors in Entertainment & Sports (Series B), Investors in SMB Software (Series B), Investors in E-commerce (Series B), Investors in Enterprise (Series B), Investors in Los Angeles / Southern California (Other Lists)
Photo of Will Geiger, Principal at Touchdown Ventures
Will Geiger
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Los Angeles (CA)
Investors in Material Science (Seed), Investors in Manufacturing (Seed), Investors in Retail (Seed), Investors in Enterprise Applications (Seed), Investors in Logistics (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in Material Science (Seed), Investors in Enterprise (Seed), Investors in Manufacturing (Seed), Investors in Retail (Seed), Investors in Logistics (Seed), Investors in Enterprise Applications (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in Enterprise (Seed), Investors in Material Science (Series A), Investors in Manufacturing (Series A), Investors in Retail (Series A), Investors in Logistics (Series A), Investors in Enterprise Applications (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in Material Science (Series A), Investors in Enterprise (Series A), Investors in Manufacturing (Series A), Investors in Retail (Series A), Investors in Logistics (Series A), Investors in Enterprise Applications (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in Enterprise (Series A), Investors in Material Science (Series B), Investors in Manufacturing (Series B), Investors in Logistics (Series B), Investors in Retail (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Enterprise Applications (Series B), Investors in Material Science (Series B), Investors in Enterprise (Series B), Investors in Manufacturing (Series B), Investors in Logistics (Series B), Investors in Retail (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Enterprise Applications (Series B), Investors in Enterprise (Series B), Investors in Los Angeles / Southern California (Other Lists)
Photo of Michael Mizrahi, Principal at Fourward Ventures
Michael Mizrahi
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Los Angeles (CA)
Investors in Material Science (Seed), Investors in Wellness & Fitness (Seed), Investors in Food and Beverage (Seed), Investors in SMB Software (Seed), Investors in Entertainment & Sports (Seed), Investors in E-commerce (Seed), Investors in Material Science (Seed), Investors in Enterprise (Seed), Investors in Wellness & Fitness (Seed), Investors in Entertainment & Sports (Seed), Investors in Food and Beverage (Seed), Investors in SMB Software (Seed), Investors in E-commerce (Seed), Investors in Enterprise (Seed), Investors in Material Science (Series A), Investors in Wellness & Fitness (Series A), Investors in Food and Beverage (Series A), Investors in Entertainment & Sports (Series A), Investors in SMB Software (Series A), Investors in E-commerce (Series A), Investors in Material Science (Series A), Investors in Enterprise (Series A), Investors in Wellness & Fitness (Series A), Investors in Entertainment & Sports (Series A), Investors in SMB Software (Series A), Investors in Food and Beverage (Series A), Investors in E-commerce (Series A), Investors in Enterprise (Series A), Investors in Material Science (Series B), Investors in Wellness & Fitness (Series B), Investors in Food and Beverage (Series B), Investors in Entertainment & Sports (Series B), Investors in SMB Software (Series B), Investors in E-commerce (Series B), Investors in Wellness & Fitness (Series B), Investors in Material Science (Series B), Investors in Enterprise (Series B), Investors in Entertainment & Sports (Series B), Investors in Food and Beverage (Series B), Investors in SMB Software (Series B), Investors in E-commerce (Series B), Investors in Enterprise (Series B), Investors in Los Angeles / Southern California (Other Lists)
Photo of Mallory Shickora, Investor at Fourward Ventures
Mallory Shickora
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Los Angeles (CA)
Investors in Material Science (Seed), Investors in Wellness & Fitness (Seed), Investors in Food and Beverage (Seed), Investors in SMB Software (Seed), Investors in Entertainment & Sports (Seed), Investors in E-commerce (Seed), Investors in Material Science (Seed), Investors in Enterprise (Seed), Investors in Wellness & Fitness (Seed), Investors in Entertainment & Sports (Seed), Investors in Food and Beverage (Seed), Investors in SMB Software (Seed), Investors in E-commerce (Seed), Investors in Enterprise (Seed), Investors in Material Science (Series A), Investors in Wellness & Fitness (Series A), Investors in Food and Beverage (Series A), Investors in SMB Software (Series A), Investors in Entertainment & Sports (Series A), Investors in E-commerce (Series A), Investors in Material Science (Series A), Investors in Enterprise (Series A), Investors in Wellness & Fitness (Series A), Investors in Entertainment & Sports (Series A), Investors in Food and Beverage (Series A), Investors in SMB Software (Series A), Investors in E-commerce (Series A), Investors in Enterprise (Series A), Investors in Material Science (Series B), Investors in Wellness & Fitness (Series B), Investors in Food and Beverage (Series B), Investors in SMB Software (Series B), Investors in Entertainment & Sports (Series B), Investors in E-commerce (Series B), Investors in Material Science (Series B), Investors in Enterprise (Series B), Investors in Wellness & Fitness (Series B), Investors in Entertainment & Sports (Series B), Investors in Food and Beverage (Series B), Investors in SMB Software (Series B), Investors in E-commerce (Series B), Investors in Enterprise (Series B), Investors in Los Angeles / Southern California (Other Lists)
Photo of Samara Pollak, Senior Associate at Marcy Venture Partners
Samara Pollak
Marcy Venture Partners·Senior Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Los Angeles (CA)
Investors in Material Science (Seed), Investors in Wellness & Fitness (Seed), Investors in Food and Beverage (Seed), Investors in SMB Software (Seed), Investors in Entertainment & Sports (Seed), Investors in E-commerce (Seed), Investors in Material Science (Seed), Investors in Enterprise (Seed), Investors in Wellness & Fitness (Seed), Investors in Entertainment & Sports (Seed), Investors in SMB Software (Seed), Investors in Food and Beverage (Seed), Investors in E-commerce (Seed), Investors in Enterprise (Seed), Investors in Material Science (Series A), Investors in Wellness & Fitness (Series A), Investors in Food and Beverage (Series A), Investors in SMB Software (Series A), Investors in Entertainment & Sports (Series A), Investors in E-commerce (Series A), Investors in Material Science (Series A), Investors in Enterprise (Series A), Investors in Wellness & Fitness (Series A), Investors in Entertainment & Sports (Series A), Investors in Food and Beverage (Series A), Investors in SMB Software (Series A), Investors in E-commerce (Series A), Investors in Enterprise (Series A), Investors in Material Science (Series B), Investors in Wellness & Fitness (Series B), Investors in Food and Beverage (Series B), Investors in SMB Software (Series B), Investors in Entertainment & Sports (Series B), Investors in E-commerce (Series B), Investors in Material Science (Series B), Investors in Enterprise (Series B), Investors in Wellness & Fitness (Series B), Investors in Entertainment & Sports (Series B), Investors in Food and Beverage (Series B), Investors in SMB Software (Series B), Investors in E-commerce (Series B), Investors in Enterprise (Series B), Investors in Los Angeles / Southern California (Other Lists)
Photo of Eric Anschutz
Eric Anschutz
Sweet spot: $25K
Range: $10K - $250K
Investors in Boston (MA), Investors in San Francisco (CA), Investors in Shanghai, Investors in Los Angeles (CA), Investors in San Diego (CA), Investors in San Jose (CA), Investors in Oakland (CA), Investors in Emeryville (CA), Investors in Seattle (WA), Investors in British Columbia
Investors in Material Science (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Space (Pre-seed), Investors in Material Science (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Space (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Material Science (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in BioTech (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Material Science (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Space (Pre-seed), Investors in BioTech (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Material Science (Pre-seed), Investors in Space (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in AI (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in BioTech (Pre-seed), Investors in AI (Pre-seed), Investors in Space (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in BioTech (Pre-seed), Investors in DeepTech (Pre-seed), Investors in AI (Pre-seed), Investors in AI (Pre-seed), Investors in Material Science (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in BioTech (Pre-seed), Investors in Space (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in DeepTech (Pre-seed), Investors in AI (Pre-seed), Investors in BioTech (Pre-seed), Investors in AI (Pre-seed), Investors in Drug Delivery (Seed), Investors in Material Science (Seed), Investors in Drug Delivery (Seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Seed), Investors in Drug Delivery (Seed), Investors in Diagnostics (Seed), Investors in Material Science (Seed), Investors in Diagnostics (Seed), Investors in Generative Tech/AI (Seed), Investors in Space (Seed), Investors in DeepTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Space (Seed), Investors in Drug Delivery (Seed), Investors in Generative Tech/AI (Seed), Investors in Generative Tech/AI (Seed), Investors in Drug Delivery (Seed), Investors in DeepTech (Seed), Investors in Material Science (Seed), Investors in Generative Tech/AI (Seed), Investors in Diagnostics (Seed), Investors in Pharmaceuticals (Seed), Investors in Therapeutics (Seed), Investors in Material Science (Seed), Investors in Space (Seed), Investors in BioTech (Seed), Investors in Therapeutics (Seed), Investors in DeepTech (Seed), Investors in Space (Seed), Investors in Diagnostics (Seed), Investors in DeepTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Drug Delivery (Seed), Investors in Material Science (Seed), Investors in AI (Seed), Investors in Therapeutics (Seed), Investors in BioTech (Seed), Investors in Diagnostics (Seed), Investors in Generative Tech/AI (Seed), Investors in AI (Seed), Investors in Space (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in AI (Seed), Investors in Generative Tech/AI (Seed), Investors in DeepTech (Seed), Investors in AI (Seed), Investors in Pharmaceuticals (Seed), Investors in Material Science (Seed), Investors in Therapeutics (Seed), Investors in Diagnostics (Seed), Investors in BioTech (Seed), Investors in Space (Seed), Investors in BioTech (Seed), Investors in DeepTech (Seed), Investors in Pharmaceuticals (Seed), Investors in AI (Seed), Investors in BioTech (Seed), Investors in AI (Seed), Investors in Material Science (Series A), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series A), Investors in Material Science (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Drug Delivery (Series A), Investors in Generative Tech/AI (Series A), Investors in Space (Series A), Investors in DeepTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Space (Series A), Investors in Generative Tech/AI (Series A), Investors in Drug Delivery (Series A), Investors in Diagnostics (Series A), Investors in Material Science (Series A), Investors in Generative Tech/AI (Series A), Investors in Drug Delivery (Series A), Investors in DeepTech (Series A), Investors in Generative Tech/AI (Series A), Investors in Material Science (Series A), Investors in Space (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Therapeutics (Series A), Investors in DeepTech (Series A), Investors in AI (Series A), Investors in Space (Series A), Investors in DeepTech (Series A), Investors in Drug Delivery (Series A), Investors in Diagnostics (Series A), Investors in Pharmaceuticals (Series A), Investors in Material Science (Series A), Investors in BioTech (Series A), Investors in Generative Tech/AI (Series A), Investors in Diagnostics (Series A), Investors in AI (Series A), Investors in Space (Series A), Investors in Generative Tech/AI (Series A), Investors in AI (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in Pharmaceuticals (Series A), Investors in Therapeutics (Series A), Investors in Material Science (Series A), Investors in DeepTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Diagnostics (Series A), Investors in BioTech (Series A), Investors in Space (Series A), Investors in BioTech (Series A), Investors in DeepTech (Series A), Investors in AI (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series B), Investors in Therapeutics (Series B), Investors in Drug Delivery (Series B), Investors in Material Science (Series B), Investors in Drug Delivery (Series B), Investors in Material Science (Series B), Investors in DeepTech (Series B), Investors in Generative Tech/AI (Series B), Investors in Therapeutics (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series B), Investors in Space (Series B), Investors in Space (Series B), Investors in Diagnostics (Series B), Investors in Drug Delivery (Series B), Investors in DeepTech (Series B), Investors in Pharmaceuticals (Series B), Investors in Material Science (Series B), Investors in Generative Tech/AI (Series B), Investors in Generative Tech/AI (Series B), Investors in Generative Tech/AI (Series B), Investors in Material Science (Series B), Investors in Space (Series B), Investors in Therapeutics (Series B), Investors in DeepTech (Series B), Investors in Therapeutics (Series B), Investors in Pharmaceuticals (Series B), Investors in Space (Series B), Investors in Therapeutics (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Material Science (Series B), Investors in Drug Delivery (Series B), Investors in Pharmaceuticals (Series B), Investors in DeepTech (Series B), Investors in AI (Series B), Investors in Diagnostics (Series B), Investors in Space (Series B), Investors in Generative Tech/AI (Series B), Investors in Diagnostics (Series B), Investors in AI (Series B), Investors in Generative Tech/AI (Series B), Investors in Therapeutics (Series B), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Material Science (Series B), Investors in Pharmaceuticals (Series B), Investors in DeepTech (Series B), Investors in Diagnostics (Series B), Investors in BioTech (Series B), Investors in Space (Series B), Investors in BioTech (Series B), Investors in DeepTech (Series B), Investors in AI (Series B), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in British Columbia (Other Lists), Investors in Seattle / Portland (Other Lists), Investors in Los Angeles / Southern California (Other Lists), Investors in Boston / New England (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Get new data & insights delivered to your inbox
Firms investing in this space